Literature DB >> 12672472

Class I phosphoinositide 3-kinases.

Karen E Anderson1, Shaun P Jackson.   

Abstract

Phosphoinositide 3-kinases (PI3-kinases) are a family of enzymes that 3'-phosphorylate the inositol head group of membrane phosphoinositides. They are subdivided into three major classes (I, II and III) based on their structural homology, regulation and substrate specificity. It is now becoming clear that PI3-kinase isoforms are subject to differential regulation and may play distinct roles within the cell. PI3-kinases and their second messenger lipid products have been implicated in a plethora of cellular responses with increasing evidence for involvement in the pathogenesis of human diseases. The future development of specific PI3-kinase isoform inhibitors may offer therapeutic benefit in a broad range of clinical settings, related to cancer, inflammatory and immunological diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672472     DOI: 10.1016/s1357-2725(02)00270-4

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  17 in total

1.  Chemical synthesis and molecular recognition of phosphatase-resistant analogues of phosphatidylinositol-3-phosphate.

Authors:  Yong Xu; Stephanie A Lee; Tatiana G Kutateladze; Diego Sbrissa; Assia Shisheva; Glenn D Prestwich
Journal:  J Am Chem Soc       Date:  2006-01-25       Impact factor: 15.419

2.  Insights into the PI3-K-PKB-mTOR signalling pathway from small molecules.

Authors:  Richard M Gunn; Helen C Hailes
Journal:  J Chem Biol       Date:  2008-07-15

3.  The p110δ subunit of PI3K regulates bone marrow-derived eosinophil trafficking and airway eosinophilia in allergen-challenged mice.

Authors:  Bit Na Kang; Sung Gil Ha; Xiao Na Ge; M Reza Hosseinkhani; Nooshin S Bahaie; Yana Greenberg; Malcolm N Blumenthal; Kamal D Puri; Savita P Rao; P Sriramarao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

4.  Paraquat-induced oxidative stress represses phosphatidylinositol 3-kinase activities leading to impaired glucose uptake in 3T3-L1 adipocytes.

Authors:  Michihiro Shibata; Fumihiko Hakuno; Daisuke Yamanaka; Hiroshi Okajima; Toshiaki Fukushima; Takashi Hasegawa; Tomomi Ogata; Yuka Toyoshima; Kazuhiro Chida; Kumi Kimura; Hideyuki Sakoda; Asako Takenaka; Tomoichiro Asano; Shin-Ichiro Takahashi
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

5.  Synthesis and molecular recognition of phosphatidylinositol-3-methylenephosphate.

Authors:  Joanna Gajewiak; Yong Xu; Stephanie A Lee; Tatiana G Kutateladze; Glenn D Prestwich
Journal:  Org Lett       Date:  2006-06-22       Impact factor: 6.005

6.  Slow regulated release of H2S inhibits oxidative stress induced cell death by influencing certain key signaling molecules.

Authors:  Aman Shah Abdul Majid; Amin Malik Shah Abdul Majid; Zheng Qin Yin; Dan Ji
Journal:  Neurochem Res       Date:  2013-04-14       Impact factor: 3.996

7.  A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.

Authors:  Lisa Salazar; Tamara Kashiwada; Pavel Krejci; Paul Muchowski; Daniel Donoghue; William R Wilcox; Leslie Michels Thompson
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

Review 8.  PTEN function: how normal cells control it and tumour cells lose it.

Authors:  Nick R Leslie; C Peter Downes
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

9.  Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket.

Authors:  Mark Frazzetto; Cenk Suphioglu; Jiuxiang Zhu; Oleg Schmidt-Kittler; Ian G Jennings; Susan L Cranmer; Shaun P Jackson; Kenneth W Kinzler; Bert Vogelstein; Philip E Thompson
Journal:  Biochem J       Date:  2008-09-15       Impact factor: 3.857

10.  Role of SHIP1 in Invariant NKT Cell Development and Functions.

Authors:  Courtney K Anderson; Alexander I Salter; Leon E Toussaint; Emma C Reilly; Céline Fugère; Neetu Srivastava; William G Kerr; Laurent Brossay
Journal:  J Immunol       Date:  2015-07-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.